Agency Information Collection Activities: Proposed Collection: Comment Request, 15889-15890 [E7-6089]
Download as PDF
<![CDATA[
15889
Federal Register / Vol. 72, No. 63 / Tuesday, April 3, 2007 / Notices
and other device-oriented information.
The CDRH Web site may be accessed at
https://www.fda.gov/cdrh. A search
capability for all CDRH guidance
documents is available at https://
www.fda.gov/cdrh/guidance.html.
Guidance documents are also available
on the Division of Dockets Management
Internet site at https://www.fda.gov/
ohrms/dockets.
Dated: March 23, 2007.
Linda S. Kahan,
Deputy Director, Center for Devices and
Radiological Health.
[FR Doc. E7–6168 Filed 4–2–07; 8:45 am]
IV. Paperwork Reduction Act of 1995
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
Health Resources and Services
Administration
Proposed Project: Federally Qualified
Health Centers (FQHC) Application
Forms: (OMB No. 0915–0285 Revision)
This guidance refers to previously
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
21 CFR part 807 subpart E have been
approved under OMB Control No. 0910–
0120; and the collections of information
in 21 CFR part 801 and 21 CFR 809.10
have been approved under OMB Control
No. 0910–0485.
V. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. The guidance
and received comments may be seen in
the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday.
BILLING CODE 4160–01–S
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995,
Public Law 104–13), the Health
Resources and Services Administration
(HRSA) publishes periodic summaries
of proposed projects being developed
for submission to the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
To request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, call the HRSA Reports
Clearance Officer on (301) 443–1129.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
Number of
respondents
ycherry on PROD1PC64 with NOTICES
Type of application form
Responses
per respondent
Total number of responses
Hours per
response
Total burden hours
1,021
300
1,021
1,021
1,021
1,021
1,021
1,021
1,021
700
1,021
150
1,021
250
900
1,021
800
800
15,131
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
..................
1,021
300
1,021
1,021
1,021
1,021
1,021
1,021
1,021
700
1,021
150
1,021
250
900
1,021
800
800
15,131
3.0
12.0
0.5
0.5
6.0
15.0
12.0
0.5
1.0
0.5
1.0
1.0
0.5
0.5
6.0
1.0
1.0
0.5
..................
3,063
3,600
510
510
6,126
15,315
12,252
510
1,021
350
1,021
150
510
125
5,400
1,021
800
400
52,684
General Information Worksheet .........................................................................
P12 Planning General Information Worksheet ..................................................
BPHC Funding Request Summary ....................................................................
Institutional File Assurances ..............................................................................
Proposed Staff Profile ........................................................................................
Income Analysis Form .......................................................................................
Community Characteristics ................................................................................
Services Provided ..............................................................................................
Sites Listing ........................................................................................................
Other Site Activities ...........................................................................................
Board Member Characteristics ..........................................................................
Request for Waiver of Governance Requirements ...........................................
Compliance Matrix .............................................................................................
Health Center Affiliation Certification .................................................................
Need for Assistance ...........................................................................................
Emergency Preparedness Form ........................................................................
FTCA Form ........................................................................................................
Points of Contact ...............................................................................................
Total ............................................................................................................
Send comments to Susan G. Queen,
Ph.D., HRSA Reports Clearance Officer,
VerDate Aug<31>2005
18:30 Apr 02, 2007
Jkt 211001
Room 14–33, Parklawn Building, 5600
Fishers Lane, Rockville, MD 20857.
PO 00000
HRSA’s Bureau of Primary Health
Care (BPHC) FQHCs are a major
component of America’s health care
safety net, the Nation’s ‘‘system’’ of
providing health care to low-income
and other vulnerable populations.
Health centers care for people regardless
of their ability to pay and whether or
not they have health insurance. They
provide primary and preventive health
care, as well as services such as
transportation and translation. Many
health centers also offer dental, mental
health, and substance abuse care.
FQHCs are administered by HRSA’s
BPHC.
HRSA uses the following application
forms to administer and manage FQHCs.
These application forms are used by
new and existing FQHCs to apply for
grant and non-grant opportunities, renew their grant or non-grant
opportunities, or change their scope of
project.
Estimated of annualized reporting
burden are as follows:
Frm 00030
Fmt 4703
Sfmt 4703
Written comments should be received
within 60 days of this notice.
E:\FR\FM\03APN1.SGM
03APN1
15890
Federal Register / Vol. 72, No. 63 / Tuesday, April 3, 2007 / Notices
Dated: March 27, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review
and Coordination.
[FR Doc. E7–6089 Filed 4–2–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
ycherry on PROD1PC64 with NOTICES
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://workplace.samhsa.gov
and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs,
SAMHSA/CSAP, Room 2–1035, 1 Choke
Cherry Road, Rockville, Maryland
20857; 240–276–2600 (voice), 240–276–
2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Public Law
100–71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
VerDate Aug<31>2005
18:30 Apr 02, 2007
Jkt 211001
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln
Ave., West Allis, WI 53227, 414–328–
7840/800–877–7016, (Formerly:
Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624,
585–429–2264.
Advanced Toxicology Network, 3560
Air Center Cove, Suite 101, Memphis,
TN 38118, 901–794–5770/888–290–
1150.
Aegis Analytical Laboratories, Inc., 345
Hill Ave., Nashville, TN 37210, 615–
255–2400.
Baptist Medical Center-Toxicology
Laboratory, 9601 I–630, Exit 7, Little
Rock, AR 72205–7299, 501–202–2783,
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira
Road, Lenexa, KS 66215–2802, 800–
445–6917.
Diagnostic Services, Inc., dba DSI,
12700 Westlinks Drive, Fort Myers,
FL 33913, 239–561–8200/800–735–
5416.
Doctors Laboratory, Inc., 2906 Julia
Drive, Valdosta, GA 31602, 229–671–
2281.
DrugScan, Inc., P.O. Box 2969, 1119
Mearns Road, Warminster, PA 18974,
215–674–9310.
Dynacare Kasper Medical Laboratories,*
10150–102 St., Suite 200, Edmonton,
Alberta, Canada T5J 5E2, 780–451–
3702/800–661–9876.
ElSohly Laboratories, Inc., 5 Industrial
Park Drive, Oxford, MS 38655, 662–
236–2609.
Gamma-Dynacare Medical
Laboratories,* A Division of the
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Gamma-Dynacare Laboratory
Partnership, 245 Pall Mall Street,
London, ONT, Canada N6A 1P4, 519–
679–1630.
Kroll Laboratory Specialists, Inc., 1111
Newton St., Gretna, LA 70053, 504–
361–8989/800–433–3823, (Formerly:
Laboratory Specialists, Inc.).
Kroll Scientific Testing Laboratories,
Inc., 450 Southlake Blvd., Richmond,
VA 23236, 804–378–9130, (Formerly:
Scientific Testing Laboratories, Inc.).
Laboratory Corporation of America
Holdings, 7207 N. Gessner Road,
Houston, TX 77040, 713–856–8288/
800–800–2387.
Laboratory Corporation of America
Holdings, 69 First Ave., Raritan, NJ
08869, 908–526–2400/800–437–4986,
(Formerly: Roche Biomedical
Laboratories, Inc.).
Laboratory Corporation of America
Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709,
919–572–6900/800–833–3984.
(Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of
Roche Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A
Member of the Roche Group).
Laboratory Corporation of America
Holdings, 10788 Roselle St., San
Diego, CA 92121, 800–882–7272,
(Formerly: Poisonlab, Inc.).
Laboratory Corporation of America
Holdings, 550 17th Ave., Suite 300,
Seattle, WA 98122, 206–923–7020/
800–898–0180. (Formerly: DrugProof,
Division of Dynacare/Laboratory of
Pathology, LLC; Laboratory of
Pathology of Seattle, Inc.; DrugProof,
Division of Laboratory of Pathology of
Seattle, Inc.).
Laboratory Corporation of America
Holdings, 1120 Main Street,
Southaven, MS 38671, 866–827–8042/
800–233–6339, (Formerly: LabCorp
Occupational Testing Services, Inc.;
MedExpress/National Laboratory
Center).
LabOne, Inc. d/b/a Quest Diagnostics,
10101 Renner Blvd., Lenexa, KS
66219, 913–888–3927/800–873–8845,
(Formerly: Quest Diagnostics
Incorporated; LabOne, Inc.; Center for
Laboratory Services, a Division of
LabOne, Inc.).
Marshfield Laboratories, Forensic
Toxicology Laboratory, 1000 North
Oak Ave., Marshfield, WI 54449, 715–
389–3734/800–331–3734.
MAXXAM Analytics Inc.,* 6740
Campobello Road, Mississauga, ON,
Canada L5N 2L8, 905–817–5700,
(Formerly: NOVAMANN (Ontario),
Inc.).
E:\FR\FM\03APN1.SGM
03APN1
]]>Agencies
[Federal Register Volume 72, Number 63 (Tuesday, April 3, 2007)]
[Notices]
[Pages 15889-15890]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6089]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Comment Request
In compliance with the requirement for opportunity for public
comment on proposed data collection projects (section 3506(c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Public Law 104-13), the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
being developed for submission to the Office of Management and Budget
(OMB) under the Paperwork Reduction Act of 1995. To request more
information on the proposed project or to obtain a copy of the data
collection plans and draft instruments, call the HRSA Reports Clearance
Officer on (301) 443-1129.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Federally Qualified Health Centers (FQHC) Application
Forms: (OMB No. 0915-0285 Revision)
HRSA's Bureau of Primary Health Care (BPHC) FQHCs are a major
component of America's health care safety net, the Nation's ``system''
of providing health care to low-income and other vulnerable
populations. Health centers care for people regardless of their ability
to pay and whether or not they have health insurance. They provide
primary and preventive health care, as well as services such as
transportation and translation. Many health centers also offer dental,
mental health, and substance abuse care. FQHCs are administered by
HRSA's BPHC.
HRSA uses the following application forms to administer and manage
FQHCs. These application forms are used by new and existing FQHCs to
apply for grant and non-grant opportunities, re-new their grant or non-
grant opportunities, or change their scope of project.
Estimated of annualized reporting burden are as follows:
----------------------------------------------------------------------------------------------------------------
Responses Total Total
Type of application form Number of per number of Hours per burden
respondents respondent responses response hours
----------------------------------------------------------------------------------------------------------------
General Information Worksheet...................... 1,021 1 1,021 3.0 3,063
P12 Planning General Information Worksheet......... 300 1 300 12.0 3,600
BPHC Funding Request Summary....................... 1,021 1 1,021 0.5 510
Institutional File Assurances...................... 1,021 1 1,021 0.5 510
Proposed Staff Profile............................. 1,021 1 1,021 6.0 6,126
Income Analysis Form............................... 1,021 1 1,021 15.0 15,315
Community Characteristics.......................... 1,021 1 1,021 12.0 12,252
Services Provided.................................. 1,021 1 1,021 0.5 510
Sites Listing...................................... 1,021 1 1,021 1.0 1,021
Other Site Activities.............................. 700 1 700 0.5 350
Board Member Characteristics....................... 1,021 1 1,021 1.0 1,021
Request for Waiver of Governance Requirements...... 150 1 150 1.0 150
Compliance Matrix.................................. 1,021 1 1,021 0.5 510
Health Center Affiliation Certification............ 250 1 250 0.5 125
Need for Assistance................................ 900 1 900 6.0 5,400
Emergency Preparedness Form........................ 1,021 1 1,021 1.0 1,021
FTCA Form.......................................... 800 1 800 1.0 800
Points of Contact.................................. 800 1 800 0.5 400
Total.......................................... 15,131 .......... 15,131 .......... 52,684
----------------------------------------------------------------------------------------------------------------
Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance
Officer, Room 14-33, Parklawn Building, 5600 Fishers Lane, Rockville,
MD 20857. Written comments should be received within 60 days of this
notice.
[[Page 15890]]
Dated: March 27, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review and Coordination.
[FR Doc. E7-6089 Filed 4-2-07; 8:45 am]
BILLING CODE 4165-15-P
